Ann Arbor, MI, February 8, 2017 – Swift Biosciences, today announced that it has hired Candia Brown as Vice President of Global Marketing. Brown brings over 25 years of biotechnology experience including product development, product management and market development.

“Candia‘s deep expertise in the genomic tools market and associated applications coupled to her incredibly strong track record with successful product introductions will greatly benefit Swift,” stated Timothy Harkins, PhD, President and CEO of Swift Biosciences. “Candia’s addition to the leadership team is going to accelerate Swift’s ability to bring new library technologies and applications to the NGS market, providing new growth opportunities for the company.”

Brown’s responsibilities will include integrated brand strategy, customer support and creating market development programs to greater build Swift’s market share in the field of genomic sequencing. She will also handle general and strategic communications for the company.

Prior to joining Swift, Brown served as Director of Single-Cell Genomics at Fluidigm Corporation, a microfluidics and mass cytometry technology manufacturer, where she was responsible for market research, strategic planning, life cycle management and market development.

Brown also previously directed the strategic marketing for DNA applications within Affymetrix, Inc. including cytogenetics and genotyping product lines.  She held various positions during her tenure at Applied Biosystems, a world leader in life science and DNA sequencing technology, including product development, customer support and product marketing for DNA sequencing and PCR-based applications.  She conducted research at Applied Biosystems, the Baxter Corporation (MicroScan Division), and the Biocircuits Corporation where she developed DNA assays for human diagnostics and microbial detection.

Brown earned a Bachelor’s degree in Integrative Human Biology from the University of California, Berkeley.

About Swift Biosciences

Swift Biosciences, based in Ann Arbor, Michigan, develops novel library preparation solutions for emerging applications based on next-generation sequencing (NGS). The energetic, highly innovative company delivers on better tools to accelerate genomic discoveries and to deliver superior science. Swift Biosciences’ products are designed to help customers analyze samples faster, easier, and with greater sensitivity and accuracy while being compatible with leading instrumentation.

The company opened its doors in February 2010, and its product development enables new applications in multiple industries, including agrigenomics, pharmaceutical, academic, biotechnology, and oncology research fields. For more information, visit our Management Team page and follow Swift Biosciences on Twitter @SwiftBioSci.